<?xml version="1.0" encoding="UTF-8"?>
<p>The high degree of initiative of a significant number of companies around the globe for the development of an effective vaccine against the new coronavirus is impressive. The very form of this pandemic, with its especially devastating consequences for global economy, the uncertainty of a new disease outbreak, and the small percentage of recorded immunity in the world's population (
 <xref rid="b18-mmr-22-04-3035" ref-type="bibr">18</xref>), have put several companies of the most developed countries in a race of relentless competition. In such cases, there can only be one winner to receive the gold medal, although the rest may actually not lose too much, as the majority of these ‘losers’ will have received state funding; in this case the tax payers' money will have been used to ‘cushion’ the imminent recession they themselves will have caused with their laws of economy. The demand for the vaccine will be huge, the profit will exceed every expectation, and will therefore provide a secure investment ‘for the sake of humanity’.
</p>
